Skip to main content

Agenus Inc. (NASDAQ: AGEN) Investor Securities Class Action Lawsuit 09/06/2024

  • If you purchased a significant amount of shares of Agenus Inc. (NASDAQ: AGEN) between January 23, 2023 and July 17, 2024, and / or if you purchased any NASDAQ: AGEN shares prior to January 2023 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: November 5, 2024. NASDAQ: AGEN investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 06, 2024 - An investor in shares of Agenus Inc. (NASDAQ: AGEN) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Agenus Inc. in connection with certain allegedly false and misleading statements made between January 23, 2023 and July 17, 2024. Lexington, MA based Agenus Inc., a clinical-stage bio...



You must register (for free) or login to view the entire case.